A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
| Status: | Archived |
|---|---|
| Conditions: | Skin and Soft Tissue Infections, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2010 |
| End Date: | November 2011 |
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
The primary objective of this study is to evaluate the safety and tolerability of
intravenously administered MEDI-551 over escalating single doses in adult subjects with
Scleroderma
To evaluate the safety and tolerability of escalating single IV doses of MEDI-551 in adult
subjects with scleroderma who have at least moderate skin thickening in an area suitable for
repeat biopsy.
We found this trial at
10
sites
New Brunswick, New Jersey 08903
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials